Enhancer-dependent and -independent steps in the rearrangement of a human T cell receptor delta transgene by unknown
Enhancer-dependent  and -independent Steps in the 
Rearrangement  of a Human T  Cell Receptor 
Transgene 
By Pilar Lauzurica and Michael S. Krangel 
From the Department of Immunology, Duke University Medical Center, Durham, North 
Carolina 27710 
Summary 
The rearrangement and expression of T cell receptor (TCR.) gene segments occurs in a highly 
ordered fashion during thymic ontogeny of T  lymphocytes.  To study the regulation of gene 
rearrangement within the TCR c~/~ locus, we generated transgenic mice that carry a germline 
human TCR 5 minilocus  that includes V~I, V~2, D~3, J~l, J~3, and C~ segments,  and either 
contains or lacks the TCR ~ enhancer. We found that the enhancer-positive construct rearranges 
stepwise, first V to D, and then V-D to J. Construct V-D rearrangement mimics a unique property 
of the endogenous TCR 5 locus. V-D-J rearrangement is T  cell specific, but is equivalent in 
c~/3 and 3"/6 T lymphocytes. Thus, either there is no commitment to the c~//~ and 7/~5 T cell 
lineages before TCR 5 gene rearrangement, or if precommitment occurs, it does not operate 
directly on TCR ~ gene cis-acting regulatory elements to control TCR 5 gene rearrangement. 
Enhancer-negative mice display normal V to D rearrangement, but not V-D to J rearrangement. 
Thus, the V-D to J  step is controlled by the enhancer, but the V to D  step is controlled by 
separate elements. The enhancer apparently controls access to J~l but not D~3, suggesting that 
a boundary between two independently regulated domains of the minilocus lies between these 
elements. Within the endogenous  TCR ot/~5 locus, this boundary may represent the 5' end of 
a chromatin regulatory domain that is opened by the TCR ~ enhancer during T cell development. 
The position of this boundary may explain the unique propensity of the TCR di locus to undergo 
early V to D rearrangement. Our results indicate that the TCR ~ enhancer performs a crucial 
targeting function to regulate  TCR (5 gene rearrangement during T  cell development. 
T 
he ability of the immune system to recognize a diverse 
universe of antigens results in large part from the pro- 
cess of V-D-J recombination that assembles the genes en- 
coding antigen receptors  on T  and B lymphocytes (1-3). 
Studies of lymphocyte development reveal that the assembly 
of antigen receptor genes is under stringent developmental 
control. The rearrangement of Ig genes occurs in a stepwise 
fashion during B cell maturation, with initial D to J joining 
followed by V to D-J joining at the H chain locus, and sub- 
sequently, V to J joining at either the g or ~ L chain locus 
(1). Similarly, T cell development is characterized by the or- 
dered rearrangement and expression of TCR. genes (4-6). The 
TCR 6 locus is the first to initiate rearrangement, at day 14 
of routine fetal thymic development  (7, 8). This is rapidly 
followed by rearrangement at the TCR 3' and 3  loci, but 
TCR ot rearrangement does not begin until fetal day 17 (9-13). 
Furthermore, in mice and humans, the rearrangement of dis- 
tinct Vs and V~ gene segments occurs in a stepwise fashion 
during fetal and early neonatal life (12, 14-17). This is the 
result of programmed rearrangement rather than cellular se- 
lection as a consequence of TCR expression, since TCR 
gene mutant mice still undergo stepwise TCR 7 and 8 gene 
rearrangement in the absence of surface TCR 3`/8 expression 
(18). 
Progress has been made in understanding the mechanism 
of  V-D-J recombination (2, 3). However, the manner in which 
complex patterns of gene rearrangement are orchestrated in 
developing lymphoid cells is only poorly understood. Imma- 
ture lymphoid ceils display recombinase activity that is de- 
pendent upon the expression of the RAG-1 and RAG-2 genes, 
and that is required for TCR and Ig gene rearrangement 
(19-22). Further, all TCR and Ig gene segments are flanked 
by conserved heptamer and nonamer recombination signal 
sequences that are essential substrates recognized by the recom- 
binase machinery (23). However, recombinase activity and 
recombination signal sequences by themselves do not appear 
to provide the specificity  implied by the temporal and lineage- 
restricted rearrangement of specific gene segments. Rather, 
such targeting appears to occur via modulation of substrate 
accessibility to the recombinase (1, 3). How this is accom- 
plished is unclear; transcriptional activity, methylation status, 
and chromatin structure have all been associated with com- 
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(31) demonstrated that V-D-J rearrangement of a hybrid TCR 
/3/Ig H  chain locus test substrate integrated into the germ- 
line of transgenic mice is absolutely dependent on the pres- 
ence of the Ig H  chain enhancer (Eu) within the construct. 
This experiment argues that an enhancer can provide a req- 
uisite targeting function important for regulating gene rear- 
rangement. 
The TCR ot and C3 genes are encoded within a single com- 
plex genetic locus, with TCR C3 D, J, and C gene segments 
located between V~ and J,~ gene segments (7, 32-35).  This 
organization dictates the deletion of TCR C3 gene segments 
in cells with V,~ to J~ rearrangements, y/c3 T cells typically 
display rearranged %  C3, and B genes, but germline TCR ce, 
whereas ot/~ T  cells typically display rearranged or, B, and 
3~ genes, with TCR C3 deleted. The decision to rearrange TCR. 
c~ versus C3 is therefore a critical event in determining the fate 
of developing T  ceils. 
A number of studies have addressed  the lineage relation- 
ship of "y/c3 and ot/~ T cells. Specifically, these studies have 
asked whether T cell precursors are precommitted to attempt 
TCR. C3 or ot rearrangement, but not both (36). Alternatively, 
T  cell precursors might initially attempt TCR C3 rearrange- 
ment, and failing the expression of a functional TCR, might 
then attempt TCR ot rearrangement (11). Thus, cell lineage 
could dictate gene rearrangement, or alternatively,  gene rear- 
rangement could dictate cell lineage. Because TCR c~//3 lym- 
phocytes typically display TCR o~ rearrangements on both 
chromosomes and have deleted both copies  of the TCR C3 
locus, it is not possible to directly deduce the rearrangement 
potential of the TCR C3 locus in the cells of the c~/~ lineage. 
Indirect evidence that has accumulated from the analysis of 
extrachromosomal circular DNA in thymocytes (36),  from 
transgenic mice that carry rearranged TCR genes (37,  38), 
from the identification of a specific TCR C3 deletional rear- 
rangement in thymocytes (39),  and from the identification 
of lineage-specific  silencer elements that regulate TCR ~ ex- 
pression  (40),  all  tend  to  support  the  notion that  T  cell 
precursors may commit to the TCR 3'/C3 or or//3 lineage be- 
fore gene rearrangement. However, evidence to the contrary 
also exists, and this tissue has not been resolved conclusively 
(41, 42). 
To begin to explore the control of TCR gene rearrange- 
ment during T  cell development, we have generated trans- 
genic mice carrying a germline human TCR C3 minilocus. 
We find that this construct rearranges in a stepwise  fashion 
that in many ways mimics the endogenous TCR C3 locus. This 
has allowed us to assess the role of the intronic TCR C3 en- 
hancer in targeting the rearrangement process. Further, since 
the transgene is not embedded within the TCR c~ locus, we 
have been able to directly compare the rearrangement of this 
gene in or//3 and y/c3 T  lymphocytes, and thus explore the 
relationship between lineage determination and gene rear- 
rangement at the TCR or/c3 locus. 
Materials  and Methods 
Constructs.  The transgene V~l-V~2-D63-Jrl-J~3-E~-C~ was con- 
structed by stepwise subcloning of previously described germline 
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DNA fragments of the human TCR c5 locus (35) into pBluescript 
KS + (Stratagene, La  Jolla, CA). In the process, all XbaI sites were 
destroyed except for two that flank Ee. Step 1: A 3.9-kb XbaI frag- 
ment containing D~3 was treated with the Klenow fragment of 
Escherichia coli DNA polymerase I to generate blunt ends, and was 
cloned into similarly blunt-ended and phosphatase-treated XbaI- 
digested pBluescript. Step 2: the 10.5-kb BamHI-KpnI fragment 
containing Je3, E~, and Ce was ligated into BamHI- and KpnI- 
digested plasmid generated in step 1 to yield D~3-J~3-E~-C~. Step 
3: The 1.8-kb XbaI-XbaI fragment containing  J~l was blunt ended 
as  above and  cloned  into  BamHI-digested, blunt-ended,  and 
phosphatase-treated plasmid from step 2 to yield D~3-J~I-J~3-E~- 
C~. Step 4: A 3.1-kb XbaI-SalI fragment containing V~2 cloned 
in pBluescript was linearized within the Va2 coding region by 
digestion with PvuI, treated with T4 polymerase  to generate blunt 
ends, and religated to generate a 2-bp frame shift. Step 5: A 3.1-kb 
EcoRI fragment containing V~I cloned in pBluescript was linear- 
ized within the V~I coding region by digestion with BsmI, blunt 
ended by treatment with T4 polymerase, and phosphatase treated. 
A single 10-bp ClaI linker was then ligated into this site. Step 6: 
The mutated V~2 fragment generated in step 4 was excised from 
the plasmid  by digestion  with XbaI and Sail, blunt ended  by Klenow 
treatment,  and  cloned  into  XbaI-digested,  blunt-ended,  and 
phosphatase-treated Vrl plasmid from step 5. Step 7: Insert con- 
taining V~I and Ve2 was excised from the step 7 plasmid by diges- 
tion with Sail and NotI, and was treated with Klenow to generate 
blunt ends. This fragment was ligated into Nod-digested, blunt- 
ended,  and  phosphatase-treated plasmid from  step 3  to  yield 
Vrl-V~2-J~l-D63-J~3-E~-Cr. Step 8:  The  enhancer-negative con- 
struct was generated from the step 7 plasmid by digestion with 
XbaI to liberate a 1.4-kb fragment containing E~, followed by 
recircularization of  the  plasmid. Fragment  orientations  were 
confirmed at all steps either by digestion with appropriate restric- 
tion  enzymes, or  by nucleotide sequencing using  appropriate 
primers. The V~I and V~2 mutations were confirmed by nucleo- 
tide sequence analysis. 
Production and Analysis of Transgenic  Mice.  Plasmids  carrying the 
enhancer positive and negative constructs were purified by two 
rounds of CsC1 density gradient centrifugation.  Plasmids were 
digested with KpnI and KspI to liberate inserts of 22.5 (enhancer 
positive) and 21.1 kb (enhancer negative), which were purified by 
electrophoresis through 0.7% agarose (PurElute; Invitrogen, San 
Diego, CA) followed  by electroelution. Eluted DNA was extracted 
four times with phenol/chloroform  and once with chloroform, eth- 
anol precipitated, and resuspended  at 20 #g/ml. Fertilized  C57BL/6 
x SJL F2 eggs were microinjected  with DNA and introduced into 
the oviducts of pseudopregnant C57BL/6  x  SJL F1 females by 
the Duke University Comprehensive Cancer Center Shared Trans- 
genic Mouse Facility. Progeny tail DNA was prepared by proteinase 
K digestion as described (43). EcoRI-digested DNA was analyzed 
on Southern blots using a radiolabeled C~ cDNA  fragment to 
screen for integrated construct. 
Polymerase Chain Reaction.  Genomic DNA  (0.6 #g)  was 
amplified  for 25 cycles  in a 25-#1 reaction containing 0.2 mM dATP, 
dCTP, dGTP, and 4 mM dUTP,  50 mM KC1, 3 mM MgC12, 
0.01% gelatin, 100 mM Tris-HC1 (pH 8.3), 0.25 U Taq polymerase, 
0.2 U Uracil N-glycosylase,  and 20 pmol of each primer oligonu- 
cleotide (44). Each cycle consisted of a 45-s denaturation step at 
94~  1-min annealing at 56~  and 2-min extension  at 72~  One 
fifth of each reaction was analyzed by agarose gel electrophoresis. 
The V~I, V~2, J~l, and J~3 oligonucleotides have been described 
previously (16). Additional oligonucleotides  used were C~A: ATA- 
CCAAACCATCCGTTTTTG;  C~B: ACCTGTAGAATCTGTC- 
TTCAC;  and  5'  of D~3: CTCCATGAGACGTTTAAGTACC. 
Enhancer Control of TCR ~5 Gene Rearrangement Nucleotide sequences  were obtained after cloning of  amplified  prod- 
ucts into pBluescript KS+  as described previously (16). 
Blot Hybridization of Genomic DNA and PCR Products.  Genomic 
DNA was prepared from tissue and cell suspensions  by proteinase 
K digestion  according  to established  procedures (45). Gel electropho- 
resis, blotting, hybridization with 32p-labeled probes, and washing 
were as previously described (46). The probes used were: 5'J~1, a 
0.4-kb  XbaI-PstI fragment mapping 5' of J~l  that was isolated 
from the genomic 1.8-kb J61 XbaI fragment; J~l, a 1.4-kb PstI- 
XbaI fragment isolated from the same fragment; and 5' D~3, a 
0.5-kb HindlII-PstI  fragment isolated from the genomic 3.9-kb 
XbaI fragment carrying D~3. The C~, V~I, and V~2 probes have 
been described previously (32, 46). All probes were radiolabeled 
by the method of random hexamer priming  (47). Quantitative 
analysis of blots was accomplished using  a betascope (Betagen, 
Waltham, MA). 
Antibodies  and Flow  Cytometry.  H57-597  (biotin-conjugated 
hamster anti-mouse TCK c~/~ IgG), GL3 (K-PE-conjugated  ham- 
ster anti-mouse TCK 3//6 IgG), 30-H12 (rat anti-mouse Thy-l.2 
IgG2b), 53-6.7  (rat anti-mouse  CD8  IgG2a), GK1.5 (rat anti- 
mouse CD4 IgG), Fc Block  (rat anti-mouse FcylI receptor [CD32]), 
biotin-conjugated hamster IgG isotype control, and streptavidin- 
PE were obtained from Pharmingen (San Diego, CA). Affinity- 
purified, K-PE conjugated goat anti-hamster IgG F(ab')2 fragment 
was purchased from Jackson Immunoresearch Laboratories (West 
Grove, PA). FITC-labeled goat anti-mouse IgG and FITC-labeled 
goat anti-rat IgG were purchased from Dako Corp. (Carpinteria, 
CA). 
For flow cytometry, 1-2  x  l0  s cells were washed three times 
in 2% BSA and 0.1% sodium azide in PBS and were incubated 
in 50 #1 of the same buffer containing 20 #g/ml of appropriate 
Ab for 30 min at 4~  Cells were washed three times and were 
then resuspended in 50 #1 of the same  buffer containing the appro- 
priate second step reagent for a 30-rain incubation at 4~  in the 
dark. Cells were again washed three times, resuspended  in the same 
buffer with  1%  paraformaldehyde, and  were analyzed using  a 
FACScan  |  (Becton Dickinson & Co., Mountain View, CA). 
Cell Isolation.  Enriched splenic T cell preparations were gener- 
ated by passage of  spleen cell suspensions over a nylon wool column 
as described (48). T cells were further purified by staining with 
anti-Thy 1.2 and FITC-conjugated goat anti-rat IgG followed by 
cell sorting using a FACStar  |  (Becton Dickinson & Co.). Enriched 
splenic B cells were generated by two rounds of T cell depletion 
using anti-Thy-l.2 plus rabbit complement (48). B cells were fur- 
ther purified  by staining with FITC-labeled  goat anti-mouse F(ab') 
followed  by cell sorting. Thymic el//~ and 3"/6 T cells were purified 
by two-color staining of thymocytes (107 cells/ml) using biotin- 
conjugated H57-597 and PE-conjugated GL3 (5 #g/ml each), fol- 
lowed by FITC-streptavidin and cell sorting. In some experiments, 
thymocytes were enriched for CD4-8-  cells by two rounds of 
depletion with 53-6.7 and GK1.5. The purity of sorted popula- 
tions was assessed  by immediate  reanalysis  of the sorted sample using 
a FACScan  | 
Human  Cell Samples.  TCK ~ gene rearrangements in the T 
cell leukemia Molt-13 (46), fetal thymocyte clone Solo-15 (16), and 
a 12-wk fetal thymocyte T cell culture (16) were previously  charac- 
terized. A polyclonal V~2 + culture of 3'/~ T cells from a 16-wk 
fetal liver was kindly provided by Dr. Hergen Spits (DNAX Re- 
search Institute,  Palo Alto, CA). 
Results 
Strategy.  We constructed a rearrangement substrate from 
a series of genomic clones carrying germline elements of the 
human TCR ~ locus (Fig.  1). These included a 3.1-kb frag- 
ment carrying V~I,  a 3.1-kb fragment carrying V62, a 3.9- 
kb fragment carrying D~3, a 1.8-kb  fragment carrying J61, 
and a 10.5-kb  fragment carrying J#3 and C6 (35,  46).  The 
latter fragment also contains the previously characterized TCR 
transcriptional enhancer within the J~3-Cb intron  (49). 
D~3  was  included in  the  construct  because  it  is  the  one 
human D~ segment that is almost universally used in rear- 
ranged TCR ~ genes (16, 17, 34).  The V~I and V~2 gene 
segments were both included within the construct because 
they appear to be differentially activated during human fetal 
thymic development (16, 17). V~2 rearrangements are abun- 
dant in very early fetal thymocytes, whereas V~I rearrange- 
ments predominate in late fetal and neonatal thymocytes. Fur- 
ther, V~2 usage is restricted to 3~//~ cells, whereas V~I is used 
in both 3'/~ and cz/8 cells (50). 
We wanted the construct to serve as an innocuous reporter 
that would not influence the rearrangement of endogenous 
TCR genes via the process  of allelic exclusion.  Therefore, 
mutations were introduced into both V~I  and V~2 to de- 
stroy their open reading frames and prevent a rearranged trans- 
gene from encoding a functional TCR protein. We also wanted 
to be able to easily remove the TCR ~ enhancer from the 
TCR 6 gene rearrangement construct 
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Figure 1.  Schematic  representation  of the human 
TCR ~ minilocus.  The transgene  (top) was constructed 
from segments of the human  TCR/~ locus  (bottom). 
(Rectangles) The exons of V, D, J, and C gene seg- 
ments. (Diamond)  The TCR ~ transcriptional  enhancer. 
Mutations  were  introduced  into the V gene segments 
to prevent TCP, protein expression from rearranged 
transgenes. final construct, and have the flexibility to clone other regula- 
tory elements in its place. Therefore,  all XbaI sites within 
the construct were destroyed during the process of subcloning 
(see Materials and Methods), except for two sites that lie be- 
tween J~3 and C~ and flank the enhancer. Finally, we used 
oligonucleotide primers  specific for V61, V~2, J~l,  and J~3 
to  analyze  transgene  V-D-J rearrangement by the PCR. 
Primers were positioned such that any V-D-J rearrangement 
would yield a PCIk product of r  kb using the appro- 
priate pair of V and J primers. Specific PCR products would 
not be generated from unrearranged templates because of the 
much larger  distances between primers. 
V-D and V-D-J Rearrangement of an Enhancer-positive TCR 
8 Minilocus.  The linearized 22.4-kb enhancer-positive con- 
struct was microinjected into fertilized C57BL/6  x  SJL F2 
eggs. Southern blot analysis  identified three founders that car- 
ried a single copy of the minilocus  (data not shown). One 
of these, founder F62, carried an intact minilocus as judged 
by EcoRI digestion and  analysis with V~I, V~2, and  C~ 
probes. Another, founder F57, carried a minilocus that was 
disrupted at the 3' end. Of two EcoRI fragments detected 
by a C~ probe, the 5' fragment appeared normal, but the 3' 
fragment was altered. Since the results obtained with mice 
derived from these founders were qualitatively similar (see 
below), the structural alteration in the 3' portion of C~ does 
not significantly influence construct rearrangement. A third 
founder, F63, carried a minilocus with a 5' truncation that 
deleted the V~I gene segment, but retained  the V~2 gene 
segment.  Founders  were mated with C57BL/6  x  SJL F1 
mice to establish three transgenic lines (line A, derived from 
F57; line B, derived from F62; and line C, derived from F63). 
We noted that the transgene  was inherited by all males in 
line B, suggesting that the transgene had integrated into the 
Y chromosome. Lines A and B were used for most of the 
experiments reported in this  study. 
To assess transgene rearrangement, genomic DNA was pre- 
pared from various tissues of two mice in each of transgenic 
lines A and B. PCR was performed for 25 cycles using ap- 
propriate pairs of V and J primers. The products were elec- 
trophoresed through agarose gels, transferred to nylon mem- 
branes, and hybridized with radiolabeled  cDNA probes specific 
for the human Vel and V62 gene segments for detection. 
Parallel samples were analyzed by PCR with a pair of C~ 
primers,  and were detected with a radiolabeled C~ probe. 
These primers amplify a 0.3-kb fragment that is indepen- 
dent of construct rearrangement and therefore serves as a con- 
trol for the efficiency  of PCR in different DNA samples. The 
combinations of PCR primers and radiolabeled probes used 
detect rearrangements of the human TCR 8 transgene, but 
do not detect rearrangements of the endogenous murine TCR, 
gene (data not shown). 
As can be seen in Fig. 2,  each pair of V and J primers 
amplified products that were enriched in the thymus of neo- 
natal mice (A-26 and B-29) and in the thymus and spleen 
of older mice (A-48 and B-31). High levels of PCR products 
in neonatal thymus and low levels in neonatal spleen could 
be consistent with T cell-specific rearrangement, since there 
are only small numbers of T lymphocytes in the spleen at 
this age (data not shown).  The low level of PCR products 
detected in other tissues is most likely attributable  to blood 
contamination. PCR using C~ primers did not reveal signi- 
ficant differences in PCR efficiency from the various DNA 
sources within each panel. 
The most abundant PCR product detected in thymus DNA 
with each primer pair was approximately 0.3 kb, consistent 
with the expected size of a V-D-J rearrangement. However, 
using the primer combinations V~2-J~l and V~l-J~l, we also 
detected a product of 1.2 kb (Figs. 2 and 3 A). A product 
of this size is predicted to result from a partial rearrangement 
of V~l or V~2 to D~3. Because D83 and J~l are separated by 
only 0.9 kb in the germline configuration,  the combination 
of a V~I or V~2 primer with a J~l primer could amplify a 
V-D rearranged fragment of 1.2 kb that contains the 0.9-kb 
genomic segment between D~3 and J~l (Fig. 3 B). This rear- 
rangement would not be detected with a J~3 primer, since 
the distance between D~3 and J~3 is much greater. To prove 
that the 1.2-kb fragment indeed represented a V-D rearrange- 
ment, Southern blots  carrying this fragment were probed 
with a radiolabeled fragment (5' J~l) derived from the re- 
gion between D~3 and J~l. Whereas the V~I probe hybrid- 
ized with both the 1.2- and 0.3-kb  fragments,  the 5' J~l 
probe selectively  hybridized with the 1.2-kb fragment, thereby 
identifying it as a V~I-D~3 rearrangement (Fig. 3 A). The 
partial V61-D~3 and V~2-D~3 rearrangements are likely to be 
intermediates  in the process of transgene V-D-J rearrangement. 
Transgene V-D-J and V-D rearrangement was a consis- 
tent property of the minilocus in independent lines of trans- 
genic mice. Using V~2 and J~l primers, we detected V~2- 
D~3-J61 and V~2-D~3 rearrangements not only in line A and 
line B thymus samples, but in line C thymus samples as well 
(Fig. 3 C). Furthermore, the same primer pair was used to 
identify abundant V62-D~3-J~l and V~2-Dn3 rearrangements 
in T cell samples derived from human fetal liver and human 
fetal thymus (Fig. 3 C). Thus, as revealed by this PCR anal- 
ysis, transgene rearrangement parallels the rearrangement of 
the endogenous human TCR 6 locus. 
A second potential  intermediate in transgene rearrange- 
ment  is  D-J.  We  could  not  detect  a  0.3-kb  fragment 
representing  D~3-J~I rearrangement by PCR using 5' D~3 
and J~l primers,  even though these primers  did amplify a 
1.2-kb fragment originating from unrearranged chromosomes 
(data not shown). Furthermore, we did not detect the predicted 
D~3-J61 fragment using a J~l  probe to  analyze Southern 
blots (see  below). We therefore conclude that the transgene 
rearranges stepwise, and that the predominant pathway in- 
volves early rearrangement of V to D, and subsequent rear- 
rangement of V-D to J. The identification of abundant trans- 
gene V-D  rearrangement intermediates  is  quite  striking, 
because rearrangements  at the Ig H chain locus and at the 
TCR B locus are well documented to proceed exclusively  via 
D-J intermediates (1). However, studies of murine fetal thymo- 
cyte hybridomas (8) and human leukemias  (51, 52) have shown 
that early V-D rearrangement is a unique property of the 
endogenous TCR ~ locus (Fig. 3 C), and this property is 
clearly mimicked by the transgene. The rearrangement of the 
transgene differs slightly from the rearrangement of the en- 
46  Enhancer  Control of TCR ~5 Gene Rearrangement Figure  2.  Tissue specificity of 
TCR t3 minilocus rearrangement. 
The  indicated  primer  pairs were 
used to detect transgene rearrange- 
ments  by  PCR,  using  genomic 
DNA from thymus (T), spleen (S), 
lung (Lu),  liver (L  0, kidney  (K), and 
brain (B), or no DNA (- -) as tem- 
plates. A pair of C6 primers served 
as an internal control. The mice ana- 
lyzed were A-26 (3-wk-old), A-48 
(6-wk-old), B-29 (2-wk-old), and 
B-31 (9-wk-old). Southern blots of 
PCR products were probed with ra- 
diolabeled Ve2, Vel, and Ce cDNA 
fragments.  Autoradiographic  ex- 
posures were adjusted so that tissue 
specificity  could be assessed  in each 
panel. 
dogenous  TCR t5 locus because although  we did not detect 
D-J rearrangement of the transgene, such rearrangements were 
detected at low levels in populations of human fetal liver and 
fetal thymus T  cells (data not shown) and are well documented 
in  populations  of murine  thymocytes  (8,  53). 
Quantification of  Transgene V-D-J  and  V-D  Rearrange- 
ment.  To quantify transgene V-D-J rearrangement, we used 
as  standards  two  human  3'/6  T  cell clones,  each of which 
has a well-characterized,  single-copy TCR-6 gene rearrange- 
ment of interest.  Serially diluted  A-48  thymus and human 
cell line DNA  samples were subjected to PCR,  electropho- 
resis,  blotting  and  probing  as  described  above,  and  V-D-J 
signals were then quantified  (Fig.  4).  Signal strengths were 
linearly related to the amount of input DNA  (except at the 
highest concentrations of human cell line DNA), indicating 
that the data could be interpreted  in a quantitative  manner. 
By this analysis, about 30%  of the transgenes displayed V61- 
D~3-J~I  rearrangements,  and  about  3%  of the  transgenes 
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Figure  3.  TCR ~ minilocus V-D and V-D-J rearrangement. (A) Panels 
from the Southern blot in Fig. 2 (DNA from A-26 and B-29 thymus (T) 
and spleen (S) amplified with V~I and J~l primers) were developed  with 
radiolabeled V61 and 5' J~l probes. (/3) The amplification and detection 
of the 0.3-kb V-D-J and 1.2-kb V-D rearrangements are diagrammed. (C) 
V~2 and J51 primers were used to amplify V-D and V-D-J rearrangements 
in DNA samples from human fetal liver (L) and fetal thymus (T) T cell 
lines, and from thymuses of mice A-26 (A), B-29 (B), and C-306 (C) (6- 
wk-old). Rearrangements were detected using a radiolabeled V~2 probe. 
The panels comparing A-26 to B-29 and B-29 to C-306, are the results 
of separate  experiments. Control C8 signals were equivalent for the DNA 
samples analyzed within  each panel (data not shown). Radioactivity 
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Figure  4.  Quantification  of TCR ~ mini- 
locus V-D-J rearrangement. Serially  diluted 
samples of A-48 thymus  DNA, human  "//6 T 
cell Molt-13  DNA, and human  3'/6 T cell  Solo 
15 DNA were subjected  to PCR using  the in- 
dicated  primer  pairs and analyzed  on Southern 
blots using Vel and V~2 probes. Amplified 
0.3-kb products were quantified using a be- 
tascope. 
displayed Ve2-D~3-Je3 rearrangements.  This difference is not 
reflected in Fig. 2 because autoradiographic exposures of panels 
developed with the V~2 probe were adjusted to those devel- 
oped with the V~I probe, so that rearrangement specificity 
in lymphoid and nonlymphoid tissues  could be compared 
within each panel. A more accurate reflection of the relative 
abundance of different rearrangements  in line A thymus DNA 
is presented in Fig. 9 in which the specific activities of the 
probes and the autoradiographic exposure times were matched. 
From these experiments we estimate that V~I-D~3-J~3 and 
V~2-D~3-J~I rearrangements are nearly as abundant as V~I- 
De3-J~l and V~2-D~3-J~3 rearrangements,  respectively. Thus, 
assuming that the transgene is present as a single-copy in- 
tegration,  transgene  V-D-J  rearrangement  is  detected  in 
~60-70%  of developing thymocytes in line A. The level of 
rearrangement in line B is ~o20% of that in line A (see Fig. 
3 C; this difference is not reflected in Fig. 2 because autoradi- 
ographic exposures  were adjusted). 
We could not reliably quantify transgene V-D rearrange- 
ments by PCR because we did not have single-copy V~I-D~3 
and V~2-D~3 rearrangement controls for comparison.  There- 
fore, we attempted to quantify the rearrangements by analyzing 
Southern blots of PstI-  plus EcoRI-digested A-26 thymus 
DNA  using V~I  and J,1  probes  (Fig.  5).  We detected an 
abundant rearranged fragment of 1.7 kb with both the Vbl 
and J~l probes  and an equally abundant fragment of 3.2 kb 
with the V~I probe, as predicted for V~I-D~3-J~I and V~I- 
D~3-J~3 rearrangements, respectively. Further, we identified 
another rearranged fragment of 0.9 kb with the V~I probe, 
as predicted for V~I-D~3.  By comparing the intensities of 
Figure 5.  TCR 6 minilocus  rearrangement  analyzed  directly  on Southern  blots. (A) PstI-plus EcoRI-digested  A-26 tail DNA (germline  [G]) and 
thymus DNA (rearranged JR]) was analyzed  on Southern blots using radiolabeled  J~l and V61 probes. Similarly  digested H-46 tail DNA (G) and 
thymus DNA (R) was analyzed  on a Southern  blot using a radiolabeled  Vel probe. The expected germline (GL) and rearranged fragments  are indi- 
cated along  with their predicted sizes. Rearrangements  involving  V~2 occur at much  lower frequency  than those  involving  V~I, and are therefore  not 
considered. The expected size of a V~2-D~3-J~I rearrangement  that might  be detected  with the J6l probe is 2.9 kb. (B) V61, D~3,  J6l and Je3 segments, 
PstI and EcoRl sites, and V~I and J~l probes are mapped in the enhancer-positive  minilocus. 
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GERMLINE: 
!  TTGGGGAACT 
2 CTGTGACACC 
FETAL DAY  ]7: 
I  TTGG 
I  TTGGGGAACT 
1  TTGGGGAACT 
I  TTGGGGAA 
2 CTGTGACACE 
2 CTGTGACAC 
2 CTGTGA 
2 CTGTGACA 
NEONATAL A-26: 
I  TTGGGG 
I  TTGGG 
]  TTGGGGAA 
]  TTGGGGAACT 
]  TTGGGG 
I  TTGGGG 
1TTGGGGAACT AG 
1TTGGGGAACT A 
2  CTGTGACACC 
P  N  P  D~3  P  N  P  Jal 
ACTGGGGGATACG  ACACCGATAAA 
AGT ACTGGGGGATAC  ACCGATAAA 
ACTGGGGG  ACACCGATAAA 
GG  CACCGATAAA 
GGGG  ACACCGATAAA 
GGGGG  ACACCGATAAA 
TGGGGGATAC  ACCGATAAA 
T ACTGGGGG  GT ACACCGATAAA 
T ACTGGGGGATAC  ACCGATAAA 
ACTGGGGG  CT  T ACACCGATAAA 
ACTGGGGGATA  G  CACCGATAAA 
G  ACTGGGGGATA  GCGAAG  GT  ACACCGATAAA 
G  ACTGGGGG  GT  T  ACACCGATAAA 
T  ACTGGGGGATACG  CG  GG  CGATAAA 
GTTC  T  ACTGGGGG  TT  CACCGATAAA 
TGGGGGATACG  TCGG  ACCGATAAA 
TC  CTGGGGGATAC  EGATAAA 
TGGGGG  CCCC  ACCGATAAA 
Figure  6.  Nucleotide sequences of V-D-J rearrangements in fetal and 
neonatal thymocytes. Junctional sequences  of 0.3-kb PCR products amplified 
using V~I and J~l or V~2 and J#l primers from fetal day 17 and A-26 
thymus DNA are compared with germline sequences (top,  underlined). 
(Left) Numbers indicate V~ segment used.  Palindromic "P" nucleotides 
and template independent "N" nucleotides are identified. 
the signals for the rearranged fragments detected with the 
V~I probe, we estimate that "15%  of the V~I rearrange- 
ments in A-26 thymus are partial V+I-D~3 rearrangements. 
Consistent with the PCR data,  partial D~3-J+I rearrange- 
ments of 4.1  kb were not detected. 
Fine Structure Analysis of V-D-J  Junctions.  The recombi- 
nation signal sequences 3' of V~ and D~ gene segments dis- 
play 23-bp spacers, whereas those 5' of D~ and J~ gene seg- 
ments display 12-bp spacers (33-35). Thus, both V-D-J and 
direct V-J rearrangement would be allowed according to the 
12/23 rule. Because of the small size of the D element, PCR 
products derived from these two classes of rearrangements 
would be indistinguishable  by agarose gel electrophoresis. To 
determine whether the 0.3-kb fragments indeed represented 
V-D-J rearrangements typical of rearranged endogenous TCR 
genes, the PCR. fragments were cloned and then subjected 
to nucleotide sequence analysis. The V-D-J junction sequences 
of eight clones  derived from fetal thymus and nine clones 
derived from neonatal thymus were determined (Fig. 6). All 
of the  junctions show evidence of D segment usage. Further, 
the  junctions display all the hallmarks of typical TCR ~ V-D-J 
rearrangements, including the evidence of P nucleotides, ex- 
onucleolytic digestion of coding ends, and incorporation of 
template independent N  nucleotides (14, 16, 34, 54). As is 
the case for endogenous TCR/~ V-D-J junctions, and in ac- 
cord with the known pattern of terminal transferase expres- 
sion (55, 56), N nucleotides were absent from fetal thymo- 
cytejunctions (14, 16, 17, 54). Rather, all nucleotides in these 
junctions could be assigned as encoded by germline elements 
or as palindromic P nucleotides that are thought to result 
from the resolution of hairpin structures at the coding ends 
(54, 57). In contrast, N nucleotide incorporation was exten- 
sive in the junctions of neonatal thymocytes. 
Lineage Specificity  of TCR 8 Minilocus  Rearrangement.  Since 
transgene rearrangement is detected at high levels only in 
thymus and spleen (Fig. 2), it must, at a minimum, be lym- 
phoid specific. To establish whether rearrangement occurs selec- 
tively in T lymphocytes, T and B cell populations were purified 
from line A and B spleens by a combination of cytotoxic elimi- 
nation  and cell  sorting.  PCK  analysis using V~I  and J~l 
primers revealed transgene V-D-J rearrangement to be abun- 
dant in splenic T  cells, but undetectable in splenic B cells 
(Fig.  7 A).  Transgene  V-D rearrangement was highly en- 
riched in splenic T cells, but could nevertheless be detected 
at low levels in splenic B cells. This was true both in the 
B cell preparation from mouse A-45, where the 1.2-kb V-D 
product was readily detected, and in the B cell preparation 
from mouse B-129,  where this fragment was detected on 
longer exposures of the autoradiogram. This is clearly not 
due to residual T cell contamination, because the specificity 
of V-D-J rearrangement appeared absolute.  Similar analysis 
of V~1-J63, V~2-J~l, and V~2-J~3 rearrangements indicated 
that transgene V-D-J rearrangement was T  cell specific in 
all instances  (Fig.  7 B). 
We next sought to determine whether transgene rearrange- 
ment occurred equivalently in ot/~/and 3'/~ T  cells, or oc- 
curred preferentially in one of these cell populations. A com- 
bination of cytotoxic elimination and cell sorting was used 
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Figure  7.  TCR ~ minilocus rearrange- 
ment  in  fractionated  splenocytes.  (tt) 
Genomic DNA samples isolated from un- 
separated  splenocytes  (S),  and  purified 
splenic T (T) and B (B) cells from mice A-45 
(25-wk-old)  and B-129 (3.5-wk-old) were 
amplified  by  PCR  with  the  indicated 
primers. Southern blots were probed with 
radiolabeled V~I and C~ cDNA fragments. 
V-D-J  and V-D  rearrangements are indi- 
cated.  (B) Genomic DNA  samples from 
A-45 T and B populations were amplified 
by PCIL with the indicated primer pairs, 
and Southern blots were probed with ra- 
diolabeled  V81,  V~2,  and  C~  cDNA 
fragments. to isolate purified populations  of oe/B and 3r  T cells from 
neonatal thymus. PCR analysis using V~I and J~l primers 
revealed essentially equivalent levels of V-D and V-D-J rear- 
rangements in ~/8 and ol/B T  lymphocytes (Fig. 8). This 
experiment was repeated with additional analysis of V~l-J~3, 
V~2-J~l, and V~2-J~3 rearrangements,  without any evidence 
for an enrichment of transgene rearrangement in the 3"/8 T 
cell population (data not shown). Cross-contamination of cell 
populations  was <1% when sorted populations  were reana- 
lyzed by flow cytometry. Minilocus rearrangement in oe//3 
cells is consistent with our observation that a large fraction 
of neonatal thymocytes  rearrange the transgene (Fig. 4), since 
<1%  of neonatal  thymocytes express a TCR 3'/8.  These 
results indicate that rearrangement of the TCR 8 transgene 
is not under the control of 3,/8 lineage-specific signals in de- 
veloping thymocytes. Rather, it has the potential to rearrange 
in precursors of both y/8 and oe/B cells. 
Rearrangement of  an Enhancer-negative TCR 8 Minilocus.  To 
determine whether the TCR 8 enhancer plays an important 
role in regulating the rearrangement process, plasmid con- 
taining the enhancer-positive  minilocus construct was modified 
by XbaI digestion followed by recircularization to delete the 
1.4-kb fragment that includes the enhancer. The linearized 
21-kb enhancer-negative minilocus construct was then used 
to  generate  transgenic  mice  as  above. Four  independent 
founders were identified that carried intact  versions of the 
enhancer-negative minilocus.  Three of these, F18, F19, and 
F22, carried single-copy integrations,  whereas one, F25, car- 
ried multiple copies of the minilocus. Progeny derived from 
F25 segregated two different integration sites, one with a 
single copy, and one with two to three copies of  the minilocus. 
As a result,  a total of five different enhancer-negative trans- 
genic lines were derived from the four founders. These were 
designated lines E (from F22), F (from F18), G (from F19), 
H (from F25 multicopy integration), and I (from F25 single- 
copy integration). 
The analysis of minilocus rearrangement in thymus DNA 
from neonatal mice in each of  these transgenic lines is presented 
in Fig. 9. Thymus DNA from enhancer-positive line A served 
as a control. In this experiment, V~I and V~2 probes were 
matched for specific activity, and autoradiographic  exposure 
times were identical, allowing for a meaningful comparison 
of the relative frequencies of the different rearrangements. 
Three different  rearrangement phenotypes were discerned 
among the enhancer-negative  mice. The most common pheno- 
Figure 8.  TCR  8  minilocus 
rearrangement  in a/~8 and 3'/8 
thymocytes. Genomic DNA sam- 
ples isolated from o~/B and "y/6 
T  cells purified  from  neonatal 
thymus (3-d-old), and a no DNA 
control  (-)  were  amplified by 
PCR with the indicated primers. 
Southern blots were probed with 
radiolabeled  V~I  and  C8  frag- 
ments. V-D-J and V-D rearrange- 
ments are indicated. 
Figure 9.  Rearrangement  of an enhancer-negative TCR ~ minilocus. 
Thymus DNA from enhancer-positive (E+) mouse A-26 and enhancer- 
negative (E-) mice E-15 (2.5-wk-old), F-35 (1.5-wk-old), G55 (2.5-wk- 
old), H-46 (2.5-wk-old),  and 1-44 (2.5-wk-old) were amplified by PCR 
using the indicated primers, and Southern blots were developed using ap- 
propriately radiolabeled  probes. Probe-specific  activities  and autoradiographic 
exposures were similar. 
type was shared by lines E, F, and H. In these mice, minilocus 
V-D rearrangement appeared to occur normally. Strikingly, 
however, V-D-J rearrangement was not detected, indicating 
that the V-D to J step was selectively impaired. This PCR 
data was confirmed  by an analysis of PstI plus EcoRI digests 
of line H DNA on Southern blots using a V~I probe (Fig. 
5). A V~I-D~3 rearranged  fragment of 0.9 kb was readily 
detected, but V~I-D~3-J~I and V~I-D~3-J~3 rearranged frag- 
ments of 1.7 and 3.2 kb, respectively, were not detected, even 
on longer exposures of the autoradiograph.  Confirmatory 
Southern blot data were also obtained for transgenic line F 
(data not shown). 
Although the level of total V rearrangement (i.e., V-D  + 
V-D-J) varied among these lines of mice, the observed inhi- 
bition of the V-D to J step is independent of this variation. 
We estimate from the Southern blot in Fig. 5 that 80-90% 
of V~I gene segments had rearranged  (V-D  +  V-D-J)  in 
line A thymus. By comparison, in line H thymus fully 50% 
of V~I gene segments  had undergone V~I-D~3 rearrange- 
ment, without detectably  proceeding to V-D-J rearrangement. 
Further, we estimate from PCR that the V~I and V~2 rear- 
rangement signals in line F were 17 and 22%  of those in 
line A, respectively.  This level of  rearrangement is comparable 
with that in the enhancer-positive line B (20% of line A as 
quantified in this experiment [data not shown] and in Fig. 
3 C). However, V-D-J rearrangement is readily detected in 
line B but not in line F. 
Distinct phenotypes were displayed by lines G and I. In 
line G, no rearrangement was detected. However, in line I, 
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beit at frequencies that were reduced compared with those 
in the enhancer-positive line A. Because V-D and V-D-J rear- 
rangement still occurred in the enhancerless construct in line 
I, we analyzed T and B lymphocyte populations purified from 
line I splenocytes to ask whether the T cell specificity of rear- 
rangement was retained or lost. We found that V-D-J rear- 
rangement in line I was still  T  cell specific, and that V-D 
rearrangement was still highly enriched in T cells (data not 
shown). The simplest interpretation of this observation is 
that there are regulatory dements within the construct other 
than the TCR 5 enhancer that can function to restrict rear- 
rangement to T  cells. 
The analysis  of additional animals in each of enhancer- 
negative lines E-I indicated that the qualitative phenotypic 
differences between the mice analyzed in the above experi- 
ment are reproducible properties of the respective lineages. 
We conclude from these experiments that transgene V to D 
rearrangement is essentially normal in the absence of the TCR 
enhancer, whereas V-D to J rearrangement is severely im- 
paired. We think that the quantitative differences in the level 
of transgene rearrangement in the enhancer-positive and - 
negative lines,  as well as the phenotypic variability among 
the enhancer-negative lines, most likely results from the dom- 
inant effects of the different transgene integration sites. Such 
position effects on transgene expression are common unless 
locus control regions are included within transgene constructs 
(58-61). We suspect that the integration site in line G is par- 
ticularly inert and functions to repress transgene rearrange- 
ment, whereas the integration site in line I is particularly 
active and partially reverses the enhancer-negative phenotype. 
Nevertheless, three of three enhancer-positive lines undergo 
V-D-J rearrangement, whereas three of five enhancer-negative 
lines undergo V-D rearrangement but do not proceed to V-D-J 
rearrangement. These results argue persuasively that the TCR 
enhancer performs a crucial targeting function that regu- 
lates a specific step in TCR 6 gene rearrangement during T 
cell development. 
Discussion 
To begin to dissect the regulation of TCR gene rearrange- 
ment during T  cell development, we generated transgenic 
mice with integrated copies of a human TCR ~5 minilocus. 
The minilocus contained selected segments of the endoge- 
nous TCR ~ locus, including the V~I, V~2, D63, J~l, J~3, 
and C~ gene segments. Transgene V-D-J rearrangement was 
found to occur exclusively in T lymphocytes. In this and other 
respects, transgene rearrangement conserved significant fea- 
tures of the rearrangement of the endogenous TCR 5 locus. 
Thus, although large portions of the endogenous locus are 
excluded from the minilocus construct, important c/s-acting 
elements that control the rearrangement process are appar- 
ently conserved. 
Because we detected high levels of transgene V-D and V-D-J 
rearrangements, but could not readily identify transgene D-J 
rearrangements, our data indicate that the minilocus rear- 
ranges in stepwise fashion, first V  to D,  and then V-D to 
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J. The propensity for minilocus V-D rearrangement mimics 
a unique property of the endogenous TCR ~ locus that is 
not shared with the TCR/3 and IgH loci. TCR/3 and IgH 
rearrangements are highly ordered, with D  to J joining oc- 
curring first (1, 3). However, multiple lines of evidence argue 
that V-D and D-D joining events predominate among the 
early rearrangements at the endogenous human and murine 
TCR ~ loci. V-D and D-D rearrangements are commonly 
detected  in  CD10 +  CD19 +  human  lymphoid  precursor 
acute lymphoblastic leukemia (ALL) samples,  whereas D-J 
and V-D-J rearrangements are not detected (51,  52).  V-D 
and D-D rearrangements are detected at high frequency in 
early murine fetal thymocyte hybridomas (8) and in human 
fetal liver and fetal thymus T cell samples (Fig. 3 C). Finally, 
we have commonly detected D~2-D#3-J~I rearrangements as 
a 2.8-kb XbaI fragment in DNA from human 3'/6 T  cell 
clones and polyclonal postnatal thymocytes using a J~l probe, 
but have not observed a 4.8-kb fragment predicted for D~3- 
J,1 rearrangement (16, 46) (data not shown). This high ratio 
of D-D-J to D-J rearrangements is most consistent with ini- 
tial D-D joining,  and subsequent joining of D-D to J. 
Despite these observations, TCR ~ D-J rearrangements are 
documented to occur in murine fetal and neonatal thymo- 
cytes (8, 53). Further, we detected low levels of D~3-J~I rear- 
rangements in human fetal liver and fetal thymus T cell samples 
by PCR (data not shown). Thus, at the endogenous TCR 
locus, D  to J joining may indeed occur on chromosomes 
that had not previously undergone V-D or D-D rearrange- 
ment. The transgenic minilocus may differ from the endoge- 
nous locus only in the efficiency of the initial V to D joining 
event, once it is activated. 
We found no evidence for direct joining of V to J, despite 
the fact that V to J joining should be allowed according to 
the  12/23  rule.  On  the contrary,  all  sequenced junctions 
showed evidence of D~3 usage. This result is not due to se- 
lection for a functional TCR protein, because mutations were 
introduced into the V regions to destroy their open reading 
frames. Thus, D~3 usage must be dictated by the rearrange- 
ment mechanism itself. Early activation of V and D segment 
accessibility  coupled with efficient V-D joining would in- 
sure the incorporation of D~3 in rearranged transgenes. 
D63  is  almost  universally found  in  rearranged human 
TCR ~ genes, as is the homologous D~2 in rearranged mu- 
rine TCR ~ genes (14,  16,  17, 34,  54).  This is also likely 
to result from ordered rearrangement rather than from selec- 
tion for a functional TCR, because this is a property of both 
in-frame and out-of-frame rearranged human and murine TCR 
genes and a property of rearranged TCR ~ genes in mutant 
mice that do not express a TCR 3'/5 (18). By contrast, the 
usage  of murine  D~I  and  human  D~I  and  D62  is  not 
universal, and appears  to be developmentally regulated (14, 
16,  17,  54).  Together, these data suggest that human D~3 
and murine D62 may be the earliest gene segments to be ac- 
tivated within the endogenous TCR 5 loci. 
The lineage relationship between or//3 and 3'/6 T cells has 
been the subject of much discussion.  It was initially proposed 
that thymocytes might first activate TCR 6 and then TCR 
ot rearrangement in an attempt to generate a functional TCR, with the outcome of the rearrangement process dictating cell 
lineage (11). Subsequently, Winoto and Baltimore (36) ana- 
lyzed extrachromosomal circles that are the products of V~ 
to J,~ rearrangement,  and found TCR 6 to be in the germ- 
line configuration in such products. This result would be con- 
sistent with a lineage decision before gene rearrangement that 
dictates TCR ~ or ot rearrangement.  In support of this in- 
terpretation, other investigators have shown that c~/~ T lym- 
phocyte development can occur in transgenic mice carrying 
functionally rearranged TCR 3' and c5 genes (37, 38). How- 
ever, the analysis of gene rearrangements in routine fetal and 
neonatal thymocyte hybridomas has clearly shown that TCR 
and o~ rearrangements can coexist in individual T cell clones 
(42),  and in one study,  rearranged  TCR ~ genes were de- 
tected in extrachromosomal  circular DNA  (41). 
We found minilocus V-DoJ rearrangement to be essentially 
equivalent in or//3 and 3//6 T cells. This clearly implies that 
the cis-acting elements within the minilocus construct that 
control rearrangement  do not respond to signals  that direct 
lineage commitment.  This result would be consistent with 
the view that  there is no lineage commitment  before gene 
rearrangement.  However, it is also possible that a lineage com- 
mitment step could precede and therefore influence rearrange- 
ment, but that our minilocus construct does not include the 
cis-acting regulatory elements that are responsive to the com- 
mitment signal.  Plausible candidates for these elements might 
be 6 Rec and pseudo-J,~  (33, 39, 62).  These elements were 
shown to rearrange  in the thymus and mediate deletion of 
the TCR 6 gene,  and the activation of this rearrangement 
was postulated to be a mechanism whereby thymoc-ytes would 
commit to the TCR or//3 lineage. However, evidence to in- 
dicate that this represents the major pathway to TCR ot gene 
rearrangement in vivo has been lacking. Our results indicate 
that without intervention by 6 1Kec (or perhaps, TC1K ot rear- 
rangement),  the TCIK 6 gene could rearrange in virtually all 
developing thymocytes.  Thus,  a temporal  competition  be- 
tween 6 1Kec (or TCR or) and TCR ~ rearrangement within 
T  cells precommitted to the or//3 lineage might  determine 
the frequency with which TC1K 6 rearrangements  occur in 
the or//3 lineage.  Our results are clearly consistent with the 
detection of TCR 6 and ot rearrangements  on homologous 
chromosomes  of some T  cell clones (42). 
The analysis of TCR 6 gene rearrangement in an enhancer- 
negative minilocus argues that the two steps in the rearrange- 
ment pathway, V to D  and V-D to J, are controlled by sepa- 
rate regulatory elements.  Only V-D  to J  rearrangement  is 
severely impaired in the absence of the enhancer.  It is gener- 
ally accepted that  gene segments are activated to rearrange 
by modulating their accessibility to components of the recom- 
binase machinery (1, 3). Further, enhancer elements can func- 
tion  to  modify regional  chromatin  accessibility  (63,  64). 
Because V to D  rearrangement  still occurs in the enhancer- 
negative  minilocus,  we  infer  that  the  TCR  3  enhancer 
influences  the  accessibility  of  the  J,1  and  J63  segments 
within the construct, but does not significantly influence the 
accessibility  of  D~3  (see  Fig.  10).  This  result  is  quite 
striking,  because J61 and D~3 are separated by only 0.9 kb, 
both in the minilocus and in the endogenous TCR 3 locus. 
Our results argue that there are probably distinct cis-acting 
elements  within  the construct  that  control  access  to  Da3 
(and to V~ gene segments).  Further,  our results imply the 
presence of a domain boundary between Da3 and Jal  that 
limits the TCR ~5 enhancer to influence J  segment but not 
D segment accessibility and reciprocally, limits more 5' regula- 
tory elements to influence D  segment but not J segment ac- 
cessibility. 
Boundary elements that define independent domains of gene 
activity that are insulated from adjacent regulatory influences 
play an important  role in gene expression (for a review see 
references 65, 66). Transgenes flanked by these boundary ele- 
ments  can be insulated  from position  effects  (58-61,  67), 
promoters flanked by these elements can be insulated from 
a nearby enhancer (67-69), and mutational loss of boundary 
elements has been implicated in misregulated gene expres- 
sion (70). Our data suggest that an insulator that is perhaps 
analogous to the chicken lysozyme A element, the Drosophila 
87A7 scs element, or the chicken fl-globin 5'HS4, may re- 
side between Da3 and J~l,  and may play an important  role 
in regulating  stepwise rearrangement  of the TCR ~ gene. 
Within the endogenous TCP,. or~6 locus, this insulator may 
demarcate the 5' boundary of a regulatory domain in chro- 
matin that is opened by the TCR 6 enhancer during T cell 
development. We predict the 3' boundary to lie between Ca 
and J~ gene  segments. 
It is of interest to contrast our results with those of Ferrier 
et al. (31), who studied the role of the lymphoid specific Ig 
H  chain  enhancer  (E~) in  the  rearrangement  of a hybrid 
TCR./Ig Va-Dt3-J~-E~-C~ test construct.  In the presence of 
E~, construct D-J rearrangement  was detected in B and T 
cells, construct V-D-J rearrangement was detected in T cells, 
and construct V-D rearrangement  was essentially undetect- 
able.  In the absence of E~, all construct rearrangement  was 
ablated.  These data were interpreted  to indicate that  D  to 
J rearrangement is controlled by E~, whereas V to D-J rear- 
rangement requires,  in addition to E~, tissue-specific  regula- 
tory elements associated with V~. Because no rearrangement 
occurred without  Eu,  the enhancer  must in this case con- 
V~I  V~2  D~3  J~l  J63  E~  C6 
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I-"  ,,.l"  I  I  I[  ]  -'1  I--'-- 
I  II 
accessible  inaccessible 
Figure 10.  Diagrammatic  comparison  of the  enhancer-positive  and 
-negative  TCR  ~  miniloci.  Allowable  gene  segment  rearrangements 
(  ....  ) are interpreted  in terms  of accessible domains  of chromatin. 
52  Enhancer  Control of TCR 6 Gene Rearrangement trol access to both D andJ segments. In the TCR 6 minilocus, 
V to D joining is independent of the nearby TCR 6 enhancer, 
arguing that the enhancer controls access toJ segments only. 
The difference may be that  the boundary element  that  we 
propose to  exist between De and Je segments  may not be 
present  in  the analogous position in the TCR fl and IgH 
loci.  In the TCR 3  and IgH loci, which are characterized 
by early D-J rearrangement,  early activation of E0 or E, pre- 
sumably initiates D-J rearrangement  before V segments are 
available. In the TCR 6 locus, which is characterized by early 
V-D  rearrangement,  activation of V  and D  segments pre- 
sumably occurs before enhancer-dependent activation of  J seg- 
ments. The observation that human lymphoid precursor ALL 
samples display TCR 6 V-D and D-D rearrangements  (but 
not D-J and V-Dq), whereas T-lineage ALL samples display 
V-D-J rearrangements (51, 52), could indicate that the TCR 
enhancer is activated in the latter, but not the former cell 
population. 
Although an important  role for the TCK 6 enhancer in 
targeting  rearrangement  is clear,  the mechanism by which 
targeting occurs is not. A substantial body of literature has 
established a tight correlation between the onset of germline 
transcription  and the onset of gene rearrangement,  but re- 
cent studies argue that transcriptional activity per se may not 
be causal in driving rearrangement (28, 29, 71). The enhancer 
could provide a targeting function that is also important for 
transcriptional  activity, such as a local change in chromatin 
structure (64) or DNA methylation (27, 29). Clearly, it will 
be valuable to assay such parameters across V, D, and J seg- 
ments within the enhancer-positive and -negative transgenes 
in future experiments. In addition, c/s elements of the TCR 
enhancer that are essential for transcriptional activation have 
been identified (72, 73) and this system offers the opportu- 
nity to test the role of such elements in targeting gene rear- 
rangement.  Finally,  it should be possible to use this system 
to identify additional regulatory elements that  mediate De 
and V~ gene segment targeting,  and that function to define 
domain boundaries that restrict the influence of regulatory 
elements  to discrete regions  of the locus. 
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